Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ro 7 0207
2. Ro 7-0207
3. Ro 70207
4. Ro-70207
5. Ro7 0207
6. Ro7-0207
7. Ro70207
8. Tiberal
1. 16773-42-5
2. Tiberal
3. Ro 7-0207
4. Ornidazolum
5. Madelen
6. Ornidazol
7. 1-chloro-3-(2-methyl-5-nitro-1h-imidazol-1-yl)propan-2-ol
8. 1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole
9. 1-chloro-3-(2-methyl-5-nitro-1h-imidazol-1-yl)-2-propanol
10. Nsc 95075
11. Ro-70207
12. 1-(2-hydroxy-3-chloropropyl)-2-methyl-5-nitroimidazole
13. Chebi:75176
14. Alpha-(chloromethyl)-2-methyl-5-nitro-1h-imidazole-1-ethanol
15. Nsc-95075
16. 1h-imidazole-1-ethanol, .alpha.-(chloromethyl)-2-methyl-5-nitro-
17. Mls000028628
18. 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
19. 62xck0g93t
20. Alpha-(chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol
21. .alpha.-(chloromethyl)-2-methyl-5-nitroimidazole-1-ethanol
22. 1h-imidazole-1-ethanol, Alpha-(chloromethyl)-2-methyl-5-nitro-
23. Nsc95075
24. Smr000058726
25. Imidazole-1-ethanol, .alpha.-(chloromethyl)-2-methyl-5-nitro-
26. Ro-7-0207
27. Dsstox_cid_25420
28. Dsstox_rid_80868
29. Dsstox_gsid_45420
30. 1-chloro-3-(2-methyl-5-nitro-1-imidazolyl)-2-propanol
31. Ornidal
32. Ornidazole [usan:inn]
33. Ornidazol [inn-spanish]
34. Ornidazolum [inn-latin]
35. Ccris 9030
36. Sr-01000000256
37. Einecs 240-826-0
38. Brn 0614299
39. Unii-62xck0g93t
40. Alpha-(chloromethyl)-2-methyl-5-nitroimidazole-1-ethanol
41. (r)-ornidazole
42. Ornidazole,(s)
43. Ncgc00016723-01
44. Prestwick_584
45. Cas-16773-42-5
46. Mfcd00057960
47. Ornidazole [mi]
48. Ornidazole [inn]
49. Alpha-(chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol [german]
50. Opera_id_1555
51. Ornidazole (usan/inn)
52. Prestwick0_000164
53. Prestwick1_000164
54. Prestwick2_000164
55. Prestwick3_000164
56. (.+/-.)-ornidazole
57. Ornidazole [usan]
58. Ornidazole [mart.]
59. Nciopen2_006374
60. Ornidazole [who-dd]
61. Schembl43039
62. Bspbio_000027
63. 5-23-05-00072 (beilstein Handbook Reference)
64. Mls001424188
65. Spbio_001948
66. Ornidazole, Analytical Standard
67. Bpbio1_000031
68. Chembl1449676
69. Dtxsid4045420
70. 1-chloro-3-(2-methyl-5-nitro-imidazol-1-yl)propan-2-ol
71. Hms1568b09
72. Hms2051d22
73. Hms2093j22
74. Hms2095b09
75. Hms2234l22
76. Hms3373m17
77. Hms3393d22
78. Hms3652c03
79. Hms3712b09
80. Imidazole-1-ethanol, Alpha-(chloromethyl)-2-methyl-5-nitro-
81. Pharmakon1600-01505981
82. Bcp12975
83. Bcp13382
84. Bcp34382
85. Hy-b0508
86. Tox21_110582
87. Bbl005302
88. Bdbm50247904
89. Nsc759295
90. S3121
91. Stk629340
92. Akos005111039
93. Akos015894928
94. Ornidazole 100 Microg/ml In Methanol
95. Tox21_110582_1
96. Ab02333
97. Ac-2025
98. Am86682
99. Ccg-101064
100. Ccg-213587
101. Db13026
102. Nc00314
103. Nsc-759295
104. Ncgc00018275-02
105. Ncgc00018275-05
106. As-12121
107. Sbi-0206881.p001
108. Ab00513814
109. Ft-0630433
110. O0417
111. Sw196758-4
112. D05274
113. Ab00383044_14
114. Ab00383044_15
115. 773o425
116. A810899
117. Ornidazole Levo-;ornidazole Impurity 7;levornidazole
118. Q-201520
119. Q2358146
120. Sr-01000000256-3
121. Sr-01000000256-4
122. Brd-a42759514-001-03-1
123. Brd-a42759514-001-09-8
124. .alpha.-(chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol
125. 1-chloro-3-(2-methyl-5-nitro-1n-imidazol-1-yl)propan-2-ol
126. .alpha.-(chloromethyl)-2-methyl-5-nitro-1h-imidazole-1-ethanol
127. 1-chloro-3-(2-methyl-5-nitro-1h-imidazol-1-yl)-2-propanol #
128. Ornidazole,1(3-chloro-2-hydroxypropyl)-2-methyl-5-nitro Imidazole
129. Ornidazole, (r)-;(r)-1-chloro-3-(2-methyl-5-nitro-1h-imidazol-1-yl)propan-2-ol
| Molecular Weight | 219.62 g/mol |
|---|---|
| Molecular Formula | C7H10ClN3O3 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 219.0410689 g/mol |
| Monoisotopic Mass | 219.0410689 g/mol |
| Topological Polar Surface Area | 83.9 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 211 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Radiation-Sensitizing Agents
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)
Amebicides
Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)
Antitrichomonal Agents
Agents used to treat trichomonas infections. (See all compounds classified as Antitrichomonal Agents.)
J01XD03
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
G - Genito urinary system and sex hormones
G01 - Gynecological antiinfectives and antiseptics
G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids
G01AF - Imidazole derivatives
G01AF06 - Ornidazole
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01X - Other antibacterials
J01XD - Imidazole derivatives
J01XD03 - Ornidazole
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AB - Nitroimidazole derivatives
P01AB03 - Ornidazole
Ornidazole has known human metabolites that include (2S,3S,4S,5R)-6-[1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
21
PharmaCompass offers a list of Ornidazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ornidazole manufacturer or Ornidazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ornidazole manufacturer or Ornidazole supplier.
PharmaCompass also assists you with knowing the Ornidazole API Price utilized in the formulation of products. Ornidazole API Price is not always fixed or binding as the Ornidazole Price is obtained through a variety of data sources. The Ornidazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tiberal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiberal, including repackagers and relabelers. The FDA regulates Tiberal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiberal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiberal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiberal supplier is an individual or a company that provides Tiberal active pharmaceutical ingredient (API) or Tiberal finished formulations upon request. The Tiberal suppliers may include Tiberal API manufacturers, exporters, distributors and traders.
click here to find a list of Tiberal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiberal DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiberal active pharmaceutical ingredient (API) in detail. Different forms of Tiberal DMFs exist exist since differing nations have different regulations, such as Tiberal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiberal DMF submitted to regulatory agencies in the US is known as a USDMF. Tiberal USDMF includes data on Tiberal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiberal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiberal suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tiberal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tiberal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tiberal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tiberal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tiberal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tiberal suppliers with NDC on PharmaCompass.
Tiberal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiberal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiberal GMP manufacturer or Tiberal GMP API supplier for your needs.
A Tiberal CoA (Certificate of Analysis) is a formal document that attests to Tiberal's compliance with Tiberal specifications and serves as a tool for batch-level quality control.
Tiberal CoA mostly includes findings from lab analyses of a specific batch. For each Tiberal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiberal may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiberal EP), Tiberal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiberal USP).
